<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="52290">Mitogen</z:chebi>-activated protein kinase (MAPK) pathways regulate many cellular functions including cell proliferation, differentiation, migration and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluate genetic variation in the c-Jun-N-terminal kinases, p38, and extracellular regulated kinases 1/2 MAPK-signaling pathways and colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> risk using data from population-based case-control studies (colon: n = 1555 cases, 1956 controls; rectal: n = 754 cases, 959 controls) </plain></SENT>
<SENT sid="2" pm="."><plain>We assess 19 genes (DUSP1, DUSP2, DUSP4, DUSP6, DUSP7, MAP2K1, MAP3K1, MAP3K2, MAP3K3, MAP3K7, MAP3K9, MAP3K10, MAP3K11, MAPK1, MAPK3, MAPK8, MAPK12, MAPK14 and RAF1) </plain></SENT>
<SENT sid="3" pm="."><plain>MAP2K1 rs8039880 [odds ratio (OR) = 0.57, 95% confidence interval (CI) = 0.38, 0.83; GG versus AA genotype] and MAP3K9 rs11625206 (OR = 1.41, 95% CI = 1.14, 1.76; recessive model) were associated with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (P (adj) value &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>DUSP1 rs322351 (OR = 1.43, 95% CI = 1.09, 1.88; TT versus CC) and MAPK8 rs10857561 (OR = 1.48, 95% CI 1.08, 2.03; AA versus GG/GA) were associated with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> (P (adj) &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>Aspirin/<z:chebi fb="2" ids="35475">non-steroidal anti-inflammatory drug</z:chebi>, cigarette smoking and body mass index interacted with several genes to alter <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="6" pm="."><plain>Genetic variants had unique associations with KRAS, TP53 and CIMP+ <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>DUSP2 rs1724120 [hazard rate ratio (HRR) = 0.72, 95%CI = 0.54, 0.96; AA versus GG/GA), MAP3K10 rs112956 (HRR = 1.40, 95% CI = 1.10, 1.76; CT/TT versus CC) and MAP3K11 (HRR = 1.76, 95% CI 1.18, 2.62 TT versus GG/GT) influenced survival after diagnosis with <z:hpo ids='HP_0003003'>colon cancer</z:hpo>; MAP2K1 rs8039880 (HRR = 2.53, 95% CI 1.34, 4.79 GG versus AG/GG) and Raf1 rs11923427 (HRR = 0.59 95% CI = 0.40, 0.86; AA versus TT/TA) were associated with <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> survival </plain></SENT>
<SENT sid="8" pm="."><plain>These data suggest that genetic variation in the MAPK-signaling pathway influences <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk and survival after diagnosis </plain></SENT>
<SENT sid="9" pm="."><plain>Associations may be modified by lifestyle factors that influence <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
</text></document>